myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
Company profile
Ticker
MYO
Exchange
Website
CEO
Paul Gudonis
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
MYOMO INC
SEC CIK
Corporate docs
Subsidiaries
Myomo Europe GmbH ...
MYO stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
26 Apr 24
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Myomo Appoints Heather Getz to its Board of Directors
28 Mar 24
10-K
2023 FY
Annual report
7 Mar 24
8-K
Myomo Reports Fourth Quarter and Full Year 2023 Financial Results
7 Mar 24
8-K
Other Events
1 Mar 24
8-K
Departure of Directors or Certain Officers
22 Feb 24
8-K
Myomo Reports Preliminary Fourth Quarter Revenue and Backlog
17 Jan 24
424B5
Prospectus supplement for primary offering
17 Jan 24
Transcripts
MYO
Earnings call transcript
2023 Q4
7 Mar 24
MYO
Earnings call transcript
2023 Q3
7 Nov 23
MYO
Earnings call transcript
2023 Q2
9 Aug 23
MYO
Earnings call transcript
2023 Q1
10 May 23
MYO
Earnings call transcript
2022 Q4
13 Mar 23
MYO
Earnings call transcript
2022 Q3
11 Nov 22
MYO
Earnings call transcript
2022 Q2
6 Aug 22
MYO
Earnings call transcript
2022 Q1
11 May 22
MYO
Earnings call transcript
2021 Q4
10 Mar 22
MYO
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
SC 13G/A
Rosalind Advisors, Inc.
25 Apr 24
4
Harry Kovelman
4 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
3
Heather C Getz
28 Mar 24
4
THOMAS F KIRK
18 Mar 24
4
DAVID A HENRY
13 Mar 24
4
Harry Kovelman
13 Mar 24
4
Micah Mitchell
13 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
144
Notice of proposed sale of securities
11 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.91 mm | 6.91 mm | 6.91 mm | 6.91 mm | 6.91 mm | 6.91 mm |
Cash burn (monthly) | (no burn) | 42.36 k | 674.79 k | 668.97 k | 571.60 k | 523.44 k |
Cash used (since last report) | n/a | 292.77 k | 4.66 mm | 4.62 mm | 3.95 mm | 3.62 mm |
Cash remaining | n/a | 6.62 mm | 2.25 mm | 2.29 mm | 2.96 mm | 3.29 mm |
Runway (months of cash) | n/a | 156.3 | 3.3 | 3.4 | 5.2 | 6.3 |
Institutional ownership, Q2 2023
30.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 19 |
Opened positions | 9 |
Closed positions | 5 |
Increased positions | 2 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 1.44 bn |
Total shares | 8.75 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Hirschman Orin | 2.00 mm | $806.00 k |
AIGH Capital Management | 2.00 mm | $829.44 mm |
Packer Paul | 1.50 mm | $605.00 k |
Worth Venture Partners | 1.12 mm | $464.20 mm |
Hewlett Fund | 1.00 mm | $567.00 k |
Rosalind Advisors | 553.29 k | $3.79 mm |
CVI Investments | 240.64 k | $1.62 mm |
Citadel Advisors | 115.52 k | $59.89 mm |
Renaissance Technologies | 86.90 k | $45.00 k |
Geode Capital Management | 45.11 k | $23.38 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Apr 24 | Harry Kovelman | Common Stock | Payment of exercise | Dispose F | No | No | 2.97 | 146 | 433.62 | 133,581 |
14 Mar 24 | Kirk Thomas F | Common Stock | Buy | Acquire P | No | No | 3.5 | 50,000 | 175.00 k | 186,499 |
11 Mar 24 | Mitchell Micah | Common Stock | Payment of exercise | Dispose F | No | No | 3.51 | 5,359 | 18.81 k | 156,435 |
11 Mar 24 | Henry David A | Common Stock | Payment of exercise | Dispose F | No | No | 3.51 | 7,774 | 27.29 k | 344,419 |
News
Recap: Myomo Q4 Earnings
7 Mar 24
Myomo Q4 2023 GAAP EPS $(0.070) Misses $(0.060) Estimate, Sales $4.756M Miss $4.787M Estimate
7 Mar 24
Earnings Scheduled For March 7, 2024
7 Mar 24
Myomo Earnings Preview
6 Mar 24
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
1 Mar 24